Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher https://www.dsij.in/DSIJArticleDetail/ArtMID/10163/Articl...
Feedback
CIPLA 
Reputation: 194,042 • Sep 26, 2020 3:20 PM
Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher
Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).
Cipla’s Dimethyl Fumarate DR Caps 120mg, 240mg, and 120mg/240mg starter pack is an AB-rated generic therapeutic equivalent version of Biogen IDEC Inc’s Tecfidera. It is used in the treatment of relapsing forms of multiple...
Dalal Street Investment Journal
1 Vote
Comment
Share
NSE:CIPLA price when posted: 771.15
View Votes